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ABSTRACT
This thesis involves the use of large scale molecular dynamics simulations
and associated analysis techniques to study DNA structure and recognition.
LAMMPS (Large-scale Atomic/Molecular Massively Parallel Simulator) is a
scalable molecular dynamics code including long-range Coulomb interactions
that has been specifically designed to function efficiently on parallel platforms.
Here we describe the implementation of the AMBER98 forcefield in LAMMPS
and its validation for molecular dynamics investigations of DNA structure and
flexibility against benchmark AMBER6 code results. Extended MD
simulations on the hydrated DNA dodecamer d(CTITIGCAAAAGh and 1:1
and 2:1 drug complexes, which have previously been the subject of extensive
dynamical analysis using AMBER6, show that it is possible to obtain excellent
agreement in terms of static, dynamic and thermodynamic parameters
between AMBER6 and LAMMPS. Also, compared to AMBER6, LAMMPS
shows greatly improved scalability in massively parallel environments (Cray
T3E).
The telomerase enzyme is active in 85-900/0 of human tumours and is
therefore an important target in anti-cancer drug design. Telomerase acts at
the telomeric regions of chromosomes adding successive (TIAGGG)n
repeats causing immortalisation of the cell. Telomerase can be inhibited by
the stabilisation of G-quadruplexes which, in vitro studies show, are formed in
these telomeric regions. In order to minimise non-specific toxicity associated
with this approach it is important that the drugs preferentially bind to
quadruplex over duplex DNA. A series of novel polycyclic acridine salts have
been synthesised within our laboratories that show this property. MD studies
have been used to study alternative binding relationships of RHPS4 (our lead
compound) to quadruplex and duplex DNA and to explore the differences in
binding profiles of RHPS4 and its methyl derivative RHPS3. Analysis of
extended simulations (> 3ns) has been carried out including evaluation of I1G
from enthalpic and entropic contributions, linear interaction energy, stacking
interactions and molecular interaction potentials. "Correct" binding positions
for RHPS4 in quadruplex and duplex DNA have been found and simulations
and analysis of RHPS3 also carried out. Although the results are not
conclusive and do not all agree with the experimental data we can conclude
that quadruplex verses duplex selectivity is governed by a subtle balance
between many factors, including electrostatic and vdW interactions, DNA
flexibility and most probably the models used.
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Chapter 1 - The important structural and functional aspects of DNA
CHAPTER1 -THEIMPORTANTSTRUCTURALAND
FUNCTIONAL ASPECTS OF DNA.
1.1 DNA structure and its biological significance
1.1.1 The discovery of DNA
One of the most significant scientific accomplishments of the last few
centuries has been the discovery of DNA. In 1868, whilst researching the
physiology of human lymph cells Friedrich Miescher discovered a
phosphorous-containing substance which he named 'nuclein'. This was
actually a nucleoprotein and it wasn't until 1889 that the protein free 'nucleic
acid' was obtained by Richard Altmann (Portugal & Cohen, 1977). Over the
next few decades the components of nucleic acids were discovered, the
phosphate group, the sugar moiety and the bases - guanine (G), adenine
(A), thymine (T) and cytosine (C) (Figure 1.1).
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Figure 1.1 - The four bases of DNA, from left to right - adenine, guanine,
cytosine and thymine.
Although at this point it was recognised that deoxyribonucleic acid (DNA)
formed a major part of the cell's nucleus, the idea that its role was to carry
genetic information was not known. This information did not emerge until
there was a more in-depth knowledge of the structure of DNA.
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outside of the helix exposed to water and the bases on the inside of the helix
(Blackburn and Gait, 1996).
1.1.2 The double helix
Watson and Crick took all this information on board and came up with the
double helix. Two anti-parallel strands are wound around each other with the
phosphate groups on the outside and the bases on the inside, as Franklin
suggested. These strands are made up of nucleotides (phosphate group,
deoxyribose sugar and hetrocyclic base) stacked upon each other in a 5', 3'
arrangement (Figure 1.3).
Figure 1.3 - The 5', 3' arrangement of nucleotide stacking (taken from Neidle,
1994).
Chargaffs rules were explained by complementary hydrogen bonding of
bases - adenine with thymine and guanine with cytosine, now known as
Watson-Crick base pairs (Figure 1.4). Combining the facts that there are two
anti-parallel strands and the four bases always pair in a certain way Watson
and Crick began to see how DNA could carry genetic information. At the end
of their paper describing the double helix they wrote, lilt has not escaped our
3
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notice that the specific pairing we have postulated suggests a possible
copying mechanism for the genetic material" (Watson & Crick, 1953).
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Figure 1.4 - Watson-Crick base pairing, from left to right - A-T and G-C,
dashed lines represent hydrogen bonding.
A number of forces, mainly the hydrogen bonds between base pairs and the
hydrophobic nature of these bases, hold the helical shape together. The
hydrogen bonding between bases holds them in a planar arrangement so
that they stack neatly upon each other with an inter stack distance of 3.4A,
van der Waals interactions also play a part in this interaction. The
hydrophobicity of the bases becomes important when we think of the
hydrated solvent environment DNA is normally found in. The bases are
hydrophobic and therefore are found in the centre of the helix away from the
solvent and the hydrophilic sugar phosphate backbone is open to the solvent.
The helix structure leads to the formation of grooves within the DNA, the
major and minor grooves (Figure 1.5). These grooves are important for DNA
functionality and bind various proteins and drugs as discussed in section
1.2.2. These grooves can be of different depths depending on the overall
form of the DNA i.e. the grooves in B-form DNA are quite deep and well
pronounced compared to other forms.
4
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standard B-form DNA there are 10.5 base pairs, the height of one complete
turn, the helix pitch, is 35.7A and the helix diameter is 20A (Sinden, 1994).
1.1.3.2 Base parameters
Base parameters either involve the two bases or a pair of successive base
pairs and fall into two categories, rotational and translational, as described in
Figures 1.6 and 1.7 below. These are the standard definitions as agreed
upon at an EMBO Workshop on DNA Curvature and Bending in 1988
(Dickerson et ai, 1989). The most common parameters have standard B-
form values of: shift =O.oA, slide =o.oA, rise =3.4A, tilt =6.0°, roll =0.0°
and twist =34.4°.
+z
3'
+y
Co-ordinate frame
Opening (cd
Twist (.m
Tip (8)
Propeller twist (w)
Roll (p)
Inclination (.,)
Buckle (K)
TIlt (T)
Figure 1.6 - Definitions of rotations involving 2 bases of a pair (top 2 rows)
and 2 successive base pairs (bottom row). In the top row, the motions of the
bases are co-ordinated, and in the middle row their motions are opposed.
Columns at the left, centre and right describe rotations about the z, y and x
axes respectively. The standard co-ordinate frame is def"med at the upper left
(taken from Dickerson et al, 1989).
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+y
+z
3'
r
z
Co-ordinate frame
Stagger (5",,)
Rise (Oz)
y displacement (dy)
Stretch (5y)
lilide (Oy)
x displacement (dx)
Shear (5x)
Shift (Ox)
Figure 1.7 - Definitions of translations involving 2 bases of a pair (top 2 rows)
and 2 successive base pairs (bottom row). In the top row, the motions of the
bases are co-ordinated, and in the middle row their motions are opposed.
Columns at the left, centre and right describe translations along the z, y and x
axes respectively. The standard co-ordinate frame is defined at the upper left
(taken from Dickerson et al, 1989).
There are other forms of DNA, discovered more recently, which exist by
utilising more than two strands, three stranded (triplex) and four stranded
(quadruplex) structures are also known. The existence of quadruplex DNA,
its structure and its possible role in the fight against cancer will be discussed
further in Chapter 4. The parameters describing the deformation and
flexibility of these higher ordered DNA structures are not yet as common as
those for the B-form duplex.
7
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direction. During this process the newly synthesised mRNA strand trails as
the double helix reforms behind the elongation complex. Termination occurs
when the full gene has been transcribed. The RNA polymerase then stops
binding to the DNA template and the mRNA strand that has been
synthesised is released from the polymerase (Matthews et ai, 1997).
Following on from transcription in the biosynthesis of proteins is the process
of translation. The mRNA is translated via 3 lettered codons (the letters refer
to the bases e.g. A,C,G,U) to transfer RNA (tRNA). Each amino acid has its
own tRNA therefore the letters in the codons relate to specific amino acids.
Peptide bonds are formed between the sequence of amino acids and a
protein is assembled.
1.1.5 Consequences of DNA damage
If a piece of DNA becomes damaged in any way, for example by a drug
administered to the body or by environmental effects, it is these two
important processes that are affected the most. Sometimes these effects are
advantageous i.e. a common property of chemotherapeutic drugs is to
prevent replication from occurring. The theory behind this kind of treatment
is that a cancerous cell will divide much faster than an ordinary cell thus it is
mainly the cancer cells which are more sensitive to interference with their
DNA. Other times the damage can cause problems i.e. if a single DNA base
that is part of an encoding region of DNA becomes mutated, its transcription
can lead to the wrong protein or a mutant protein being synthesised.
Cancer is one of the most common diseases caused by the transcription
process going wrong. There are three types of genetic alteration or mutation
which are known to lead to cancer, these mutations occur in oncogenes,
tumour suppressor genes and genes that normally govern true replication of
DNA e.g. DNA repair enzymes and cellular checkpoint genes (Oliff, 1999).
Mutations arising in oncogenes generally result in what is known as "gain of
function" changes to their encoded proteins (see example below), in contrast
11
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to this mutations arising in tumour suppressor genes and DNA repair
enzymes tend to result more in "loss of function" changes to their encoded
proteins.
1.1.5. 1 Example: The ras oncogene
An oncogene is described, in simple terms, as a gene that has the capability
of causing cancer (Franks & Teich, 1995), one such oncogene is the ras
oncogene. The normal ras gene encodes a GTP binding protein involved in
signal transduction. This ras protein stimulates a cascade of events that
culminate in the activation of nuclear transcription factors. The intrinsic
activity of the ras protein is to convert active ras-GTP to inactive ras-GDP. A
single nucleotide mutation to the ras gene (Franks &Teich, 1995) is enough
to cause a defect in the activity of the ras protein such that it is always in the
active ras-GTP form. This leads to the cell receiving a false signal to activate
growth-promoting genes (Matthews et ai, 1997). This leads to a gain in
function where cells are able to grow indefinitely, i.e. they become immortal,
a possible sign of cancer.
Mutated ras genes, of which there are three types - H-ras, K-ras and N-ras,
are found in 20-30% of all human tumours but most commonly found in
pancreatic cancer, colon cancer and adenocarcinoma of the lung (Oliff,
1999). Ras is a target for potential anti-cancer drugs and a number are now
in development, for example, antisense oligonucleotides specific to the ras
mutation of a gene which can be used to block mRNA translation (Leonard,
1997).
1.2 DNA Recognition
DNA recognition is a very important process within the human body. DNA
sequences have to be recognised by the corresponding proteins and
enzymes to enable the function to be carried out. For example, the initiation
12
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stage of transcription could not take place if the RNA polymerase enzyme did
not recognise the specific promoter sequence which signals the start of an
encoding region of DNA.
The recognition of a piece of DNA can occur in two ways, firstly there is
general (non-specific) recognition of any nucleotide or sequence, for example
the packaging of DNA by histones, and secondly there is specific recognition
whereby the ligand in question will recognise only a certain piece of DNA
(nucleotide or sequence), for example restriction endonucleases which
protect DNA by "cutting out" alien DNA (where the wrong base has been
transcribed or a base has become mutated).
The mechanism of indirect readout (non-specific recognition) tends to occur
through contacts made via the sugar-phosphate backbone, whereas direct
readout (specific recognition) is more likely to occur through the same
mechanism a single strand of DNA uses to recognise another - hydrogen
bonding via the bases. Other mechanisms for readout of bases include
electrostatic potential, steric effects and hydration.
1.2.1 Protein-DNA recognition
Protein-DNA interactions are occurring all the time within the body as almost
all functions of DNA are carried out in conjunction with proteins. Most
proteins tend to bind to the major groove as it is generally the site of direct
readout of base sequence, also their structural motifs such as the a-helix are
generally too large to fit into the minor groove, although some smaller
proteins are known to bind in the minor groove, for example the TATA-box
binding protein, discussed later.
There are three main types of protein involved in DNA interactions:
regulatory, enzymatic and structural. The interaction of regulatory proteins
involves the recognition of specific sequences of DNA to set off a cascade of
events that can lead to gene expression (protein biosynthesis) or DNA
13




















Chapter 2 - Molecular Modelling methodology and analysis techniques.
The Amber98 forcefield (Cornell et aI, 1995) has parameters defined for use
in modelling biological molecules such as proteins and nucleic acids.
Once the forcefield parameters and equation have been established, these
can then be used to generate molecular structures and obtain structural and
energetic data for these structures. Two molecular mechanics methods
commonly used for this are energy minimisation and molecular dynamics.
2.1.2 Energy Minimisation
Energy minimisation is used to find the lowest energy conformation for a
molecule. There can be many different conformations of the same molecule
and each will have a different energy. Conformations with steric clashes etc.
tend to have high energies and therefore the conformation with the lowest
energy is likely to give the most stable state. This variation in energy is
known as the "potential energy surface"I this surface can have many peaks
and troughs but it is the energy at the bottom of the lowest trough that we are
most interested in and this is known as the "global energy minimum" (Figure
2.4). The global energy minimum is very difficult to find as most minimisation
algorithms can only find the nearest energy minimum to the starting structure.
To get out of one trough and into another requires energy to be put into the
system and will be discussed further in the section on Molecular Dynamics.
There are two methods generally used in energy minimisation, these are the
steepest descent method and the conjugate gradient method.
34
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Energy
A: Energy minimisation
Configuration
B: Molecular dynamics
Configuration
Figure 2.4 - In energy minimisation (A), different initial guesses (e) for the true
structure may be optimised to local (+) rather than the global (*) energy
minimum. Using molecular dynamics (B) the global energy minimum may be
more reliably identified (Figure courtesy of Charles Laughton).
The steepest descent method, as its name suggests, finds the steepest
direction on the energy surface to move down. A step down the slope is
taken and if the energy decreases the step is increased by a factor until the
energy starts to increase. A smaller value for the step length is then taken
and the search continues until a minimum is found, although convergence
around the minima is slow (Hirst, 1990). The conjugate gradient method is
similar to the steepest decent in that the first step is equivalent. Subsequent
steps are performed along a line that is a mixture of the current negative
gradient and the previous search direction (Jensen, 1999) i.e. a conjugate
gradient. This provides much better convergence when approaching a
minimum although, as the previous gradient is stored to be used in the next
calculation, it does require more computer power. It is therefore common to
use both these methods when carrying out energy minimisation, steepest
descent is used first as a quick route down the energy well and then
conjugate gradient is used to home in more precisely on the minimum.
35
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2.1.3 Molecular dynamics
Molecular dynamics (MD) is used to study the dynamical motion of a system
over time. Successive conformations of a system are generated by
integrating Newton's equations of motion, resulting in a trajectory that
specifies how the positions and the velocities of all the atoms within the
system vary with time. Each atom in the system is considered to be a point
mass whose motion is determined by the forces exerted upon it by all the
other atoms in the system, as described by Newton's first law, "A body
continues to move in a straight line at constant velocity unless a force acts
upon it" (Leach, 2001). The change in force between two atoms or
molecules is calculated continuously with their separation. This continuous
nature requires the equations of motion to be integrated by breaking the
calculation down into a series of very short time steps (eft), typically 1
femtosecond. At each step the forces on the atoms are calculated (via
solving the differential equations of Newton's second law, F=ma; Equation 6)
and combined with the current positions and velocities to generate new
positions and velocities as short time ahead. The force acting upon each
atom is assumed to be constant during the time interval. The atoms are then
moved to the new positions, an updated set of forces is computed and so on.
This is how an MD simulation creates trajectories that describe how the
particles in the system vary with time.
Equation 6 - The motion of a particle of mass mr, along a co-ordinate Xi, with
F(xi) being the force on the particle in that direction.
2.1.3.1 Time steps
The size of the time step used to create the trajectory is very important as the
smaller the time step used the better the approximation of the trajectory. A
small time step however, means that more steps are required to propagate a
36
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system of given time, i.e. the computational costs increase inversely with the
size of the time step (Jensen, 1999). The size of the time step required
depends upon the timescale of the motions under investigation. A typical
time step is 1 fs because this is the smallest time scale of motions within a
molecule and corresponds to high frequency bond stretching vibrations. In
the simulation of biological macromolecules, the algorithm SHAKE (Ryckaert
et ai, 1997) is often used which constrains the bond lengths within a system
so that a faster 2 fs time step can be used. In large systems such as proteins
and nucleic acids, eliminating bond vibrations does not affect the integrity of
the system but when angle-bending motions are constrained the integrity is
no longer maintained (Schlick et ai, 1997). The use of SHAKE therefore is
restricted to bond lengths only but does reduce the computational costs
required for simulations.
2. 1.3.2 Periodic boundary conditions
It is commonplace in biological MD simulations to immerse a solute in a
solvent box to represent the solvated environment of the molecule. In doing
so one can also implement periodic boundary conditions where an infinite
lattice is formed using this solvated box. To realistically model a solution,
several hundreds of water molecules are needed, although this can lead to
outer solvent molecules boiling off into space and to surface effects (Jensen,
1999). Periodic boundary conditions are used to overcome these effects. In
the course of the simulation, as the molecule in the original box moves, its
periodic image in all the other boxes moves in exactly the same way. If a
molecule (or part of a molecule) leaves the original box, one of its periodic
images will enter the box through the opposite face (Allen &Tildesley, 1987),
therefore bulk properties ensue where there are never "outer molecules" and
there is never a surface with which to interact.
37
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2.1.3.3 Treatment of electrostatic interactions
The treatment of electrostatic interactions is of great importance when
simulating highly charged systems such as nucleic acids. The polyionic
nature of a DNA backbone, and its immersion in a solvent box, requires a
particularly accurate treatment of the electrostatics especially long-range
forces. Prior to 1995, simulations of DNA were plagued by instabilities
caused by inaccurate truncation methods for calculating the Coulomb
potential. These truncation methods used a finite cut-off distance of around
10-12A, after which the interaction energy between non-bonded atoms was
considered to be zero (Louise-May et aI, 1996). Truncation was used, as it
required less computational cost than the more accurate lattice sum
methods.
Lattice sum methods can be used to calculate all non-bonded interactions by
imposing a crystal-like periodicity to the MD system (similar to periodic
boundary conditions). The Ewald summation method (Ewald, 1921) is one
such method and works by splitting the interaction into short- and long-range
contributions separated by a cut-off. The short-range term is evaluated
directly while the long-range term is calculated in reciprocal space (Jensen,
1999). The related methods Particle Mesh Ewald (PME; Darden et aI, 1993)
and Particle-Particle Particle-Mesh (PPPM; Hockney & Eastwood, 1998) use
the Ewald summation but are much faster due to the use of Fourier methods
to calculate a smoothly varying long-range term (Sagui & Darden, 1999). It is
these faster methods that lead to stable nucleic acid trajectories of
nanosecond proportion in 1995 (Cheatham et aI, 1995) and are still used in
present day calculations.
The use of PME imposes a quasi-crystalline periodicity that could cause
artificial stabilisation of the simulation system. This effect will depend upon
the size of the periodic box, so that a box that is too small would produce
crystal like behaviour and a box that is too large would expend unnecessary
computational effort. Simulations have been performed on the DNA
sequence d(CGCGAAAAAACG)2 (Norberto de Souza & Ornstein, 1997) in
38
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solution with differing sizes of solvent box (5, 10 and 1sA from the solute to
the edge of the box). The root mean squared deviation (RMSD) of these
three systems from the initial co-ordinates was monitored to detect if the
flexibility of the system was altered by any crystal packing effects. No
significant differences were found between the systems; therefore concluding
that a minimum sA water layer is acceptable to allow normal dynamical
behaviour of DNA in solution, although a cautionary 10A layer is
recommended as other systems may behave differently to the one used in
the study.
2.1.3.4 Validation of MD methods for use on nucleic acids
To critically assess the feasibility of the MD program AMBER, and its related
forcefield, for the study of DNA, Young et aI, (1997) carried out a number of
simulations, up to Sns in length. The key issues they were concerned with
were; treatment of boundary conditions, electrostatics, initial placement of
solvent and run lengths. They chose the established Dickerson & Drew
(1981) dodecamer d(CGCGAATTCGCGh as a test model as it is often used
for benchmarking systems in experimental and theoretical studies. The MD
results showed a dynamically stable structure of B-form DNA, which
compared favourably with crystallographic and NMR studies of
d(CGCGAATICGCG)2. Molecules of solvent were mobile and able to gain
access into the minor groove, reproducing the "spine of hydration", DNA
bending was seen, with this bending supporting the "junction model" (for
more details see Chapter 3), one of two mechanisms for bending proposed
from experimental studies. Also sequence effects on groove widths were
reproduced. Their findings show that accurate all-atom MD, stable on the ns
timescale, using explicit solvation can give accurate descriptions of the DNA
in solution and produce ideas about the nature of dynamic structure and
solvation.
Many other simulations have been carried out to validate the use of MD,
some of which are discussed in the next chapter. Others can be found in
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reviews on MD studies of DNA by Cheatham & Kollman (2000) and by
Cheatham &Young (2001).
Recently the forcefield parameters of AMBER have been updated (Cheatham
et aI, 1999) to more accurately represent sugar pucker phases and helical
repeat. These modifications lead to improved agreement with experimental
data.
2.1.3.5 Implicit solvation models
The solvent environment plays an important role in molecular structure and
dynamics, for example, DNA duplex formation (and the formation of higher
ordered DNA structures) and its subsequent structural type (e.g. B-form) is
dependent on the ionic strength of the surrounding solvent. It is therefore
important when simulating a biological molecule that the solvent is correctly
described. Simulations normally use explicit solvation where every atom in
the system (including all solvent atoms) is described. This tends to make
computational costs high because of the need for accurate long-range
electrostatic calculations. Implicit solvation models have been developed
which treat the solvent as a continuum electrostatic model and is therefore a
much faster method, as there are no long-range interactions to consider.
The Generalised Born (GB; Still et aI, 1990) model is one such model and
has been implemented in the AMBER modelling package (Case et aI, 1999)
with an additional solvent accessible surface area term (SA) that can be
turned on or off, as needs suffice (see below). The solvation free energy
(Gsol) can then be described as a combination of a solute-solvent
electrostatic polarization term (Gpol) , a solvent cavity term (Gcav) , and a
solute-solvent vdW term (GvdW ) as in equation 7 (Still et aI, 1990).
G: == Gpol +Gi: +G:«
Equation 7 - The GBSA equation describing solvation free energy.
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The first Gpol term denotes the electrostatic contribution and can be
calculated via equation 8, the GB equation.
1
G pO' == - 2
-re GR
1---
Equation 8 - The generalised Born equation, where K is the Debye-Huckel
screening parameter, JOB depends upon effective Born radius (ai) and the
interaction distance between atoms (rij), e is the dielectric constant and qi and
CJJ are the partial charges.
The last two terms (Gcavand GvdW) are associated with the formation of a
cavity within the solvent and are related to SA by equation 9. If the free
energy difference being computed is between two systems of very similar
surface, the SA term can be switched off to reduce calculation time.
Gs:+G:« == L a, SAk
Equation 9 - Equation describing the formation of a cavity within solvent,
where k is the atom type and a is a surface tension term.
The GBSA model has been used to simulate macromolecules such as DNA
and proteins with reasonable results (Jayaram et aI, 1988; Tsui & Case,
2001) and speed compared with explicitly solvated systems. Simulations of
DNA can reproduce structural aspects quite well, in particular the transition
from A-form to B-form DNA in low salt conditions (Tsui & Case, 2000),
although a recent study within our group (Sands & Laughton, 2003) has
shown that dynamical and especially thermodynamical properties are not
always as well reproduced.
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2.2 Analysis methods
2.2.1 Principal Component Analysis
Molecular dynamics simulations provide a vast amount of data which needs
to be "mined" to extract relevant information. A method for extracting this
information is Principal Component Analysis (PCA). PCA for the analysis of
biomolecular simulations, in particular, was developed by the Berendsen
group (Amadei et aI, 1993) and has since proved to be a powerful tool in
studying conformational behaviour in nucleic acids and proteins. It is a
statistical method for analysing MD trajectories and can be used to find the
components that make up the greatest overall contribution to the motion
within a trajectory. It can also be used to obtain entropies via the Schlitter
method and to gain insights into how similar trajectories of the same system
are via the overlap method of Hess (see later).
A 3N x 3N covariance matrix of the Cartesian co-ordinates is generated from
an MD simulation, then diagonalised to give 3N eigenvectors. The
eigenvectors provide a vectorial representation of each component of
structural deformation (Sherer et aI, 1999), i.e. they indicate the direction of
motions of the atoms. Each eigenvector has a corresponding eigenvalue that
indicates the relative contributions made by the component to the motion as
a whole. The eigenvectors associated with the highest eigenvalues can be
selected for further analysis.
Projections of the trajectory along the major eigenvectors give useful
information on equilibrium and conformational sampling (Wlodek et aI, 1997).
To ease the interpretation of the deformations associated with each principal
component, short MD trajectories (animations) can be generated artificially
by generating structures in which the projections vary linearly between the
minimum and maximum values observed (Sherer et aI, 1999). The resulting
animations can be inspected visually using VMD (Humphrey et aI, 1996).
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2.2. 1. 1 peA Overlap
PCA of a trajectory produces a description of the essential quasi-harmonic
modes of deformation (eigenvectors) of the structure, as discussed above.
Motion along each eigenvector relates to an orthogonal way in which the
structure samples configurational space. If two separate simulations of a
system are dynamically equivalent, they must sample this space the same
way. This can be achieved if they have the same eigenvectors, or linear
combinations of each other. For DNA the first ten eigenvectors from all
simulations capture the majority of the important modes of flexibility of the
system and so a comparison of these is sufficient (for proteins more may be
required; Charles Laughton/Daniel Warner, personal communication). To
quantify this comparison we used the eigenvector overlap measure of Hess
(2000), calculated as the normalised sum of the dot products between a
given number of eigenvectors from two separate simulations (Equation 10).
Equation 10 - The Hess overlap equation, where a and b are the eigenvector
matrices to be compared and n denotes the number of eigenvectors.
2.2. 1.2 Calculation of entropy via the Schlitter method
Configurational entropies can be calculated from mass-weighted eigenvalues
according to the method of Schlitter (Schlitter, 1993). The Schlitter method is
an IIupgrade" of the Karplus method developed much earlier (Karplus &
Kushick, 1981), in which the entropy is described by the summation of the
natural logarithm of the eigenvalues (Equation 11).
1S == -kLlnA
2
Equation 11 - Simplified version of the Karplus equation, S is the entropy, k
is the Boltzmann constant and A is the eigenvalue.
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The Karplus method leads to inaccuracies in entropy because of the small
eigenvalues associated with the highest frequency modes. Although these
inaccuracies do not contribute greatly to the overall dynamics of the system,
they do contribute to the entropy as the logarithm becomes large and
negative for these eigenvalues with values of much less than one. One
possible solution to this problem was to use cut-offs, beyond which the
eigenvalues were considered to be negligible. This method also leads to
inaccuracies, because all the eigenvalues contribute to the entropy, the
results which are obtained are biased heavily by where this cut-off is taken.
The Schlitter method differs from the Karplus method in two ways. Firstly the
eigenvalues are mass weighted and secondly, to overcome the problem of
large negative entropies for eigenvalues less that one, the logarithm of one
plus the eigenvalue is taken (Equation 12) so that the logarithm of the
eigenvalues is never negative.
Equation 12 -The Schlitter equation, S is the entropy, k is the Boltzmann
constant, T is the temperature (in K), e is the Euler number, h is Planck's
constanti.ll1 and Am is the mass weighted eigenvalue.
Summation of the Schlitter equation for all eigenvalues therefore gives a
more valid approximation of the configurational entropy of a system than the
Karplus method. This has been shown in a comparison of the two methods
by Schafer ef al (2000).
Entropies calculated by this method are sensitive to the length of the MD
simulations - in essence, longer simulations tend to lead to a fuller
exploration of conformational space by the molecule and to higher calculated
configurational entropies. However, we find that the dependence of the
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calculated entropy S(t) on the simulation length t can be fitted very well to a
function (Equation 13).
A8(t)==8 --
<Xl t n
Equation 13 - Function describing how to obtain the inf"mite entropy of a
system, S(t) is the calculated entropy, Boo is the infinite entropy, t is the
simulation length and n and A are fitting parameters, n being related to the
time correlation in the dynamics.
So from the fitting procedure, the entropy for a simulation of infinite length S<Xl
(in addition to the other parameters of the fit, A and n) can be estimated.
2.2.2 Linear Interaction Energy (LIE)
The Linear Interaction Energy (LIE) approach was developed by Aqvist and
co-workers (1994), to provide an alternative to the time consuming Free
Energy Perturbation (FEP) method for calculating relative or absolute binding
affinities. In FEP the free energy is calculated for the perturbation of one
molecule into another, thus the ~ ~ between two states is found. It is only
possible to carry out FEP between molecules that differ slightly. The method
requires the accumulation of ensemble averages along the perturbation path,
which must be fine grained in order for the free energy to converge. In
practise, drug design often deals with large molecules and derivatives that
differ quite greatly and so a simplified method that could deal with these
molecules was sought.
LIE is used to calculate free energy changes, using only electrostatic and van
der Waals interactions, based on simulations of only two states. In the case
of ~ G b i n n the two states are the solvated ligand and the ligand bound to
solvated protein/DNA. The method is based on the linear response
approximation for electrostatic forces, which for polar solutions will yield
harmonic free energy functions in response to changes in electric field
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(Aqvist et aI, 1994). The approximation to the electrostatic contribution of the
binding free energy is shown in equation 14.
L1 Gel "-I I A el )
bind "-I a \ L.J..comp-drug
Equation 14 - The electrostatic contribution to LIE, where Q is a fitting
parameter.
The value of a is determined from the knowledge that the electrostatic
contribution to the solvation energy of a single ion is equal to half of the
corresponding ion-solvent interaction energy. The value of 11elcomp-drUg, the
difference in electrostatic interaction between the two drug environments, is
obtained from simulations of the solvated drug and of the solvated drug-
protein/DNA complex.
The vdW part of LIE represents the non-polar interactions and is calculated in
a similar fashion to the electrostatic part. No analytical theory exists for the
calculations of this part but there was indirect evidence that a similar linear
treatment would work, using a different fitting parameter (Leach, 2001).
Experimental free energies of solvation for various n-alkanes have an
approximate linear dependency on the length of carbon chain. Also the
mean vdW solute-solvent energies from simulations of n-alkanes showed a
similar linear variation. From these observations Aqvist and co-workers
hypothesised that a simple linear approximation similar to that of the
electrostatics would be able to account for the non-polar binding contribution
(Equation 15).
A c: "-I pi A vdW )L..l bind "-I \ L.J..comp-drug
Equation 15 - The van der Waals contribution to LIE, where ~ is a fitting
parameter.
The value of J3 was found by fitting the equation to experimental data, Aqvist
and co-workers generated a J3 value of 0.161. The value of 11vdW comp-druq- the
difference in vdW interaction between the two drug environments, is
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obtained, as before, from simulations of the solvated drug and of the solvated
drug-protein/DNA complex.
The two parts of the equation can then be put together (equation 16) to form
the overall LIE equation.
Equation 16 - The LIE equation.
The LIE equation has been used in several studies to obtain free energies of
binding, with reasonably good results (Hansson & Aqvist, 1995; Wall et aI,
1999; to name a few). However, the transferability of the fitting parameters of
Aqvist et al are not always successful, leading various groups to generate
their own parameters (Paulsen & Ornstein, 1996; Jones-Hertzog &
Jorgensen,1997). It was suggested at first that the vdW parameter ~ was
forcefield dependent, but this was later discounted after simulations were
repeated using different forcefields (CVFF, GROMOS, AMBER) and still gave
the same value of ~ (Paulsen & Ornstein, 1996; Aqvist, 1996; Wang et aI,
1999). Simulations on a number of differing systems lead to the conclusion
that a fixed ~ parameter could not give results in agreement with
experimental data in all cases. It was therefore suggested that the value of ~
is dependent on the system and its environment and if possible should be
determined for each different system used. Less speculation has surrounded
the other fitting parameter a as this is approximated analytically, although it
has been noted by Hansson et al (1998) that the theoretical value of 0.5
decreases slightly as the number of hydroxyl groups increases.
2.2.3 Molecular Interaction Potential (MIP)
The calculation of the Molecular Interaction Potential (MIP) is based upon the
quantum mechanical molecular electrostatic potential (MEP) with a further
addition of a classical repulsion-dispersion term. This results in a method to
represent accurate electrostatic interactions and also steric effects. MEP can
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be described as the electrostatic component of the interaction energy
between a molecule and a positive charge. Calculations of MEP give us
valuable information about general topology, location and depth of MEP
minima and the averaged information provided by charges derived from the
fitting of the MEP and the Coulombic potential (Orozco & Luque, 1992). One
of the biggest drawbacks of MEP is its inability to describe steric effects.
This drawback restricts its use in molecular host-guest studies, which are
popular for the screening of ligands in drug design. To overcome this,
Orozco and Luque (1992) have added a Lennard-Jones type 6-12 repulsion-
dispersion contribution to the total interaction energy to create the MIP
(Equation 17).
Equation 17 - The MIP equation, where rs is the position of the positive
charge.
The MIP associated with the interaction of a probe molecule (of positive
charge) with the time averaged structure of the subject molecule is calculated
at points on a 3D grid surrounding the area of interest (binding site). Regions
of negative potential describe favourable interactions between probe and
subject molecule.
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CHAPTER 3 - THE VALIDATION OF LAMMPS FOR
MOLECULAR DYNAMICS SIMULATIONS OF DNA
3.1 Review of DNA dynamics
DNA is not a static molecule, but highly flexible and dynamic. Subtle
changes in the flexibility, and therefore shape, of DNA are important in the
recognition process, especially for sequence specific recognition and it is
because of this that the study of DNA dynamics, and not just structure, is so
important. If we can begin to understand the dynamical behaviour of DNA
we can begin to understand more about the complex nature of its functions.
While there are many biophysical experiments available to study structural
properties of DNA, there is no experimental technique capable of generating
a complete description of the dynamical behaviour of DNA. For this we need
to turn to theoretical techniques such as Molecular Dynamics (MD) described
in Chapter 2. MD can provide a theoretical description of both DNA
structure and dynamics and, as such, is a useful tool not only for developing
DNA models but also for helping to interpret experimental data.
3.1.1 The advent of MD as a tool for studying DNA dynamics
The first MD study of DNA was reported back in 1983 (Levitt, 1983) and
since then the field has grown rapidly. Early studies of DNA did not include
the solvent nor ionic environment, although the importance of water and
counter-ions were recognised as an integral part of DNA structure (Westhof,
1988). The inclusion of the ionic environment did not arrive until better
methods for the treatment of long-range electrostatics were available (see
previous chapter). The treatment of electrostatics is crucial in the study of
DNA because of its charged sugar-phosphate backbone. Also if a piece of
DNA is to be solvated in a true representation of its environmental
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surroundings (water and counter-ions), the long-range electrostatics must
also be taken into account to obtain a stable structure.
Before ca. 1995, simulations of DNA were plagued by instabilities mainly due
to the application of approximate methods that lacked the ability to correctly
represent highly charged systems. Simulations of proteins with explicit
solvent were already rather robust and reliable at this time (very few proteins
have an overall charge of any magnitude) but simulations of DNA were
characterised by distortion of duplex structures, broken base-pairing and
misrepresented sequence specific fine structures (Cheatham & Kollman,
2000). Simulations of this era were also rather short «500ps), which as we
know today is not always long enough to reach equilibrium.
Since 1995, DNA simulations have become much more reliable. With more
computing power than ever before, better forcefields (Cornell et aI, 1995;
MacKerell et aI, 1995) and more accurate methods available especially for
calculating long-range electrostatics (PME see previous chapter), it is now
feasible to obtain stable DNA structures and dynamics to timescales of tens
of nanoseconds (Auffinger & Westhof, 1998; Cheatham & Kollman, 2000;
Beveridge & McConnell, 2000; Cheatham & Young, 2001). The reliability of
these codes has been shown by the stability of simulations to longer time
scales, reproduction of experimental data and the reproducibility of the
simulation results.
3.1.2 Reproduction of experimental data via MD
The reproduction of experimental data is important not only to show the
reliability of the codes and forcefields, but also to show the reliability of the
method itself. The examples below show that MD, as a method, can
reproduce experimental data including the topics of environmental effects (A-
form - B-form transitions), structural flexibility (A-tract bending) and
thermodynamic analysis (Co-operativity in DNA binding).
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3.1.2.1 Example: A-form - B-form transitions
The major structural family of DNA involves the right-handed A- and B-form
structures. There is a 5.7A RMSD difference between canonical A- and S-
forms with the major differences relating to sugar pucker, the angle between
base pairs and the helix axis, the rise between base pairs (leading to an end-
to-end length of -30A for B-form and -23A for A-form for a decamer) and the
width of the minor groove (larger in A-form than B-form). The base
parameters (see section 1.1.3.2) that have the largest deviations between
forms are x-displacement (B-form = -1.0-0.oA, A-form = -6.0-5.oA) and
inclination (B-form --6.0°, A-form >19°; Saenger, 1984).
It has been known for many years that DNA can adopt different forms
depending of its environmental surroundings. The effect of the environment
on DNA ranges from global changes based on the solvent and ionic
concentrations leading to conversions between A- and B-form structures, to
more local structural effects caused by changes in the helical parameters. It
was this A-form to B-form transition which was used by Cheatham and
Kollman to show that the Cornell et a/. (1995) forcefield could reproduce the
experimental data which showed that B-form structures are more stable at
low salt and high humidity than A-form (Cheatham & Kollman, 1996).
Cheatham and Kollman carried out four unrestrained nanosecond length
simulations in aqueous solution on the duplex d(CCAACGTTGGh, with the
Cornell et a/. (1995) forcefield. Two of the simulations were started from a
canonical A-form structure and two from a canonical B-form. RMSD
calculations showed that the average structures from the four trajectories
converged to with 0.8-1.6A of each other and to 3.1-3.6A from the S-form x-
ray structure reported for this sequence (Prive et aI, 1991). The A-form to B-
form transition takes place, in the simulations, on an approximately 500ps
timescale (Experimentally, there are conflicting reports on the timescale of
these transitions, studies on DNA films and fibres show that the transition can
take hours or days (Szabo ef aI, 1996) whereas other experiments show the
transition is rapid and highly reversible; Piskur & Rupprecht, 1995). At the
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time this was the only demonstration of an A-B transition occurring during
unrestrained MD, but since then a number of other studies have shown
similar results (Cieplak et aI, 1997; Miller & Kollman, 1997; Shields et aI,
1997).
3.1.2.2 Example: A-tract bending
Curvature of DNA is an important topic in structural biology because it is this
curvature, or bending, that allows DNA to bind to many of the proteins
involved in its everyday functions, for example chromatin. Chromatin
complexes are involved in the packaging of DNA into chromosomes. They
are nucleoproteins involving -145 base pairs of DNA wound around a
histone protein core.
Some sequences are known to have an inherent tendency to bend, even
when no protein is present, e.g. A-tract sequences. A-tracts involve runs of
adenines on one strand and thymines on the other. The first observation of
naturally occurring curved DNA was seen by Marini et al (1982) in kinetoplast
DNA). This sequence had extensive repeats of A-tracts within it and further
studies showed that bending occurred when A-tracts were repeated in phase
with the helical repeat itself (Crothers et aI, 1990) i.e. every 10-11 base pairs.
This phasing is critical as it forces the A-tract to be on the same side of the
helix all the time therefore allowinq the small individual A-tract bends to
magnify to a large overall bend. Gel studies demonstrate that A6 A-tracts are
bent by 17-21 0 in the direction of the minor groove (Koo et aI, 1990).
The precise nature of this bending is not fully understood and has led to a
number of models being put forward. The two main models are the junction
model and the wedge model (Figure 3.1).
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sequence without A-tracts (composed of three repeats of the of BamH1
recognition sequence) was also carried out (Young & Beveridge, 1998).
Results from the simulations show axis bending to the extent of 16.50 per A-
tract compared with experimental values of 17-21 0 , leading to an overall
bend of 26-30 0 compared with 180 for the control sequence. The model also
shows a 5' to 3' narrowing of the minor groove region of the A-tracts, a
feature inferred by DNA footprinting studies. Other studies carried out in
several laboratories have supported the idea of straight A-tracts with bending
most likely to occur at the junctions, but also extending into the general
sequence region as well (Beveridge & McConnell, 2000 and references
therein).
3. 1.2.3 Example: Co-operativity in DNA binding
In recent years it has become increasingly clear that some of the most
important factors that drive recognition are not always enthalpic - e.q.,
related to an understanding of specific interactions made between the drug
and the DNA - but are often entropic (Haq et ai, 1997). And while it has
been assumed that the major contribution to the entropy changes that
accompany drug-DNA recognition comes from solvent reorganisation, it has
been recently shown (Harris et ai, 2001) that changes in the configurational
entropy of the DNA can also be vitally important. While estimates of the
enthalpic components of a recognition process may readily be made from the
examination of static (e.g. X-ray crystallographic) structures by molecular
modelling methods, and estimates of solvation effects may also be made
from such information, they provide no clues at all as to any configurational
entropic factors. For this we must have information about the dynamical
behaviour of the DNA and the ligand, and how it changes between the bound
and unbound state.
It has been shown by combining NMR structure determination methods with
extended molecular dynamics simulations that there are important changes
to the dynamics and flexibility of the DNA decamer duplex
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the second drug molecule could then take place with little further stiffening
effect, and so was favoured.
The reliability of calculations of this type is critically dependent on the
possibility of obtaining extended molecular dynamics trajectories. It was
found that as the simulation length increases so does the calculated
configurational entropy, as the DNA samples new areas of conformational
space. The increase is not linear, but tends to a limit, and while a limit can
be estimated quite reasonably by curve fitting, the process requires
considerable extrapolation beyond currently accessible simulation
timescales, and so is open to dispute. Improvements to studies of this type
clearly require order-of-magnitude increases in simulation times, but since
current simulations of this type typically already consume months of CPU
time, this is not a realistic option for day-to-day studies.
3.1.3 Timescale issues
MD simulations are increasingly proving their worth for the fuller
understanding of biomolecular structure and dynamics (Karplus &
McCammon, 2002). In the search for ever-more realistic and observationally
useful simulations, the pressure has been on the practitioner to simulate
increasingly complex systems (e.g. proteins in membranes) for increasing
lengths of time. The rationale behind this is straightforward: the behaviour of
a biomolecule in vivo is highly dependent on its environment, and the
treatment of this in anything less than atomistic detail generally produces
results that are unacceptable for biological purposes, although implicit
models of solvation (Hawkins et aI, 1996; Weiser et aI, 1999) are now
showing some promise.
The desire for extended simulations is driven by a number of factors. Firstly,
MD simulations are often used as a form of structure optimisation, where
initially constructed models are allowed to relax through MD until some sort
of equilibrated state is achieved. The complexity of many systems makes
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this a process impossible to achieve through deterministic energy
minimisation alone (due to the multiple minimum problem) but it is often very
slow by MD. Secondly, MD simulations are perhaps the only method
available for the study of dynamical processes at the atomic level of detail,
the example par excellence being protein folding (Duan & Kollman, 2001;
Fersht & Daggett, 2002; Wu et aI, 2002). Thirdly, even if the time-evolution
of a system is not of interest, MD simulations are often used as an efficient
method of generating a thermodynamically relevant ensemble of structures
for a biomolecule from which thermodynamic parameters may be calculated
(Beveridge & DiCapua, 1989; Kollman, 1993; Kollman et aI, 2000). The
accuracy of these calculations depends critically on the conformational
sampling from the MD, and for large systems with important low-frequency
modes of conformational flexibility, simulations of many nanoseconds at least
may be required (cfthe protein folding problem itself).
Many of the important conformational changes that DNA can undergo take
place on the micro- to millisecond timescale (Table 3.1; Yakushevich, 1998)
- for example the 'breathing' of the bases (see example below). A simulation
of this length (1 microsecond) has been carried out of a protein folding
intermediate in explicit solvent (Duan & Kollman, 1998), but this is the only
one of its kind. Long simulation times (50-160ns; Daggett, 2000) have been
observed for other peptides and small proteins but bigger and longer
simulations of DNA are much more difficult to obtain with present codes.
This is due to the need for more accurate solvation and electrostatic
calculations, as already discussed, as these calculations use the most
computer time and power. To obtain these types of simulation for DNA we
will have to wait for technological advances to catch up with our
requirements.
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Time s c ' ~ i T e - - M a i i types of internal motion
--PicOSecond-----Shorflivin-g moti-o-ns ,in-a--oscillations o ( a t o m s ~ - - --------- - - ~ ~
Nanosecond Oscillations of small groups of atoms: sugars, phosphates,
bases; bending and twisting of the double helix.
Microsecond Winding and unwinding of the double helix; opening of base
pairs.
Millisecond Dissociation of the double helix; super helicity; overall rotation.
Second Writhing; isomerisation; division of bacteria.
Table 3.1 - The time scales of the internal mobility of DNA (adapted from
Yakushevich, 1998).
3.1.3.1 Example: Base pair breathing events
Base pair breathing occurs when the normal pattern of Watson-Crick
hydrogen bonds is temporarily disrupted as a base swings out of the helix
and is exposed to solvent, or perhaps is recognised by a DNA-binding
protein. Currently, we cannot simulate this spontaneous process at the
atomic level because of timescale issues. The rate-limiting step of base pair
opening is partially related to the breaking of Watson-Crick hydrogen bonds.
It is therefore expected that DNA containing base pairs without these
stabilising hydrogen bonds will open more frequently. When thymine is
replaced by its non-polar homologue difluorotoluene (F) the duplex is only
minimally perturbed and NMR studies show that the modified base pair
(Figure 3.3) forms, remains stacked and standard B-form DNA is maintained
(Guckian et aI, 1998). Studies in chloroform show no evidence that
difluorotoluene forms hydrogen bonding interactions with adenine (Moran et
ai, 1997). Cubero et al (1999) support these findings and show that in a
10ns simulation of the duplex d(CTfTCFTfCTf)'d(AAGAAAGAAAG),
numerous base pair opening and closing events occurred.
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Figure 3.3 - Structures of standard AT (left) and its homologue AF (right).
Other methods of studying the phenomena of base pair opening include
biasing the simulation to force the breathing event (Varnai & Lavery, 2002) or
moving to non-atomistic representations where much longer timescales are
computationally feasible (Wattis et aI, 2001).
3. 1.4 Parallel processing
Parallel processing provides the most obvious approach to reducing time-to-
solution for calculations, but most common general-purpose molecular
dynamics algorithms are not well suited to parallel computing, let alone
massively parallel processing. Indeed, the more established MD life science
packages (Case et aI, 1999; Brooks et aI, 1983) are long established codes
that were not originally designed with parallel implementation in mind. The
overwhelming majority of such 'legacy' codes have been parallelised in the
most direct fashion using the so-called 'replicated data' paradigm, which
assigns the data on all atoms in an MD simulation to all N processors on the
parallel computer. Such codes scale very poorly as the size of both the
model and the numbers of processors are increased. For this reason, even
on modern supercomputers, these codes are unable to exploit such
unprecedented computing power to the full; indeed, the codes are rarely
deployed on more than a very small number of processors, a situation that
highlights the importance of 'smart' algorithms in harnessing maximum
benefit from modern parallel computers.
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An alternative paradigm, which makes use of 'spatial domain decomposition'
(Plimpton, 1995), distributes the computation over spatially disjoint domains
in the system which are handled by separate processors; thus, for N atoms
and P processors, each processor carries data on NIP atoms, and is hence
scalable to much larger systems, with far less stringent memory limitations. It
should be clear that spatial domain decomposition in particular puts heavy
demands on efficient interprocessor communication, especially for problems
in which Coulomb interactions are dominant, as their long range guarantees
that atoms on other processors influence the behaviour of those on each
local processor. For this reason, one can expect the best performance to be
delivered only on tightly coupled parallel machines, and not on less closely
coupled clusters which have recently been gaining in popularity on grounds
of cost.
3.2 Introduction to LAMMPS
LAMMPS (Large-scale Atomic/Molecular Massively Parallel Simulator;
Plimpton & Hendrickson, 1996) is a recently developed, highly scalable, MD
code which implements spatial domain decomposition and is hence suitable
for deployment on massively parallel supercomputers. In collaboration with
Peter Coveney's group from Queen Mary University, London (now at UCL,
London) we have tested the LAMMPS code for use in generating biological
simulations using the AMBER forcefield parameters. Originally the
LAMMPS99 code was used but subsequent editions of the code have been
released, with useful applications added, therefore results are shown mainly
for the LAMMPS2000 and LAMMPS2001 codes (website 1).
3.2.1 Validation using the Hoechst system
If LAMMPS and similar "parallel" codes are to gain widespread acceptance, it
is vital that they are shown to produce results that agree with those obtained
using the older, more established codes, such as AMBER. The aim of this
section of the thesis is to use LAMMPS to reproduce as closely as possible
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Practical issues regarding differences in time-stepping, temperature coupling
and treatment of long-range electrostatics, as well as the intrinsically chaotic
nature of molecular dynamics (which means that phase space trajectories
can be expected to diverge exponentially fast regardless of how close the
initial conditions) mean that simulations run using LAMMPS can never be
expected to be identical to those run using the AMBER code, despite the use
of the same forcefield. However, a series of benchmark comparisons have
been established and implemented that can be made between the results of
two simulations produced using two different architectures and/or software
codes, to provide stringent and quantitative measurements of similarity
despite this problem. However, as we shall show, with due care the
dynamical behaviour (and derived thermodynamic parameters) of a DNA
system simulated using LAMMPS is in good agreement with that obtained
using AMBER, with the important advantage of greatly improved
computational efficiency on tightly coupled massively parallel processors.
3.2.2 Implementation of the AMBER forcefield into LAMMPS
LAMMPS has the inherent flexibility required to calculate bonded and non-
bonded components of molecular mechanics energy according to AMBER-
style functions. The only change to the code required was to permit separate
scaling factors to be applied to the van der Waals and electrostatic
components of 1-4 interaction energies (this is now included in the current
release of LAMMPS). Utility programs were produced to allow AMBER
coordinate and topology files to be converted into their LAMMPS equivalents,
and for LAMMPS trajectory files to be converted back into AMBER-style
ones, for compatibility with MD analysis software.
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3.3 Methods
3.3.1 Simulation protocol
All simulations in this study were run on up to sixty-four processors of an 816
processor Cray T3E-1200E supercomputer. Full details of the AMBER
simulation protocols have been given elsewhere (Harris et ai, 2001).
LAMMPS MD simulations were conducted using exactly the same
periodically-solvated DNA system. Briefly, this consists of the DNA
dodecamer d(CTTTTGCAAAAGh, 22 sodium counter-ions to establish
electrical neutrality, and 1748 TIP3P water molecules (a total of 6028 atoms).
The initial configuration of the system was taken from the NMR data
(Gavathiotis et ai, 2000) and energy minimised using AMBER. Periodic
boundary conditions were applied (initial box dimensions approximately 32A
x 36A x 52A) to a canonical (NVT) ensemble. Electrostatic interactions were
calculated by the PPPM (Hockney & Eastwood, 1988) method using a grid
order of 5 and a cut off of 9A on the direct sum. A Lennard-Jones cut-off of
9A was used for non-bonded interactions. The AMBER-specific treatment of
1-4 interactions (scaling non-bonded and electrostatic components
differently) was handled through changes to the LAMMPS code (available
now in the current LAMMPS release through use of the 'special bonds'
directive). The simulation temperature was maintained through application of
one of variety of temperature coupling options as detailed below. A dielectric
constant of 1 was used, atomic positions were dumped every ps and the
neighbour list was updated every 15 or 25 steps depending on the stability of
the simulation.
AMBER simulations typically use SHAKE (Ryckaert et ai, 1997) to constrain
all bonds, permitting a 2fs integration timestep. SHAKE was not
implemented in LAMMPS until the latest version (LAMMPS2001). Previous
versions of the code did permit multiple time-stepping, using RESPA
(Tuckerman et ai, 1991, Plimpton et ai, 1997) in which computationally
expensive terms (in particular, the non-bonded interactions) are evaluated
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less often than those requiring a small timestep (the bonded interactions).
The earliest simulations, using LAMMPS99 however, did not use RESPA
because at the time it was not compatible with the method of temperature
coupling being used (Langevin) and therefore single time-stepping (1fs
integration timestep) was used.
The protocol for LAMMPS MD studies using single time-stepping, and also
the later studies using SHAKE, consisted of a 10 ps run in which the
temperature of the system was raised from zero to 300K, then 1ns of
dynamics at T=300K to ensure equilibration. All 2 ns production runs started
with the configuration and velocities from this 1ns checkpoint. RESPA
simulations required a slower warming run to avoid problems with neighbour
list updates - 200ps warming from 0-100K, 200ps warming from 100-200K,
200ps warming from 200-300K, then 400ps equilibration at T=300K. Again,
all 2ns production runs started with the coordinates and velocities from this
1ns time point.
3.3.2 Analysis methods
Separate solute and solvent temperatures in LAMMPS simulations were
calculated from atomic velocities. Atomic Cartesian co-ordinate fluctuations
and time-averaged structures were calculated using the AMBER utility
program ptraj (website 2). Visualisation of trajectories was performed using
VMD (Humphrey et ai, 1996). Principal component analyses were performed
according to the methods previously described (In Chapter 2) using in-house
programs (Sherer et ai, 1999; Cubero et ai, 1999). The comparison of
trajectories via the calculation of eigenvector overlaps was performed
according to Hess (Hess, 2000). Individual snapshots from the LAMMPS
simulations, stripped of solvent and ions, were input to the AMBER program
sander in order to calculate energies with the Generalised Born/Surface Area
implicit solvation model (Tsui & Case, 2000), as previously described for the
AMBER simulations (Harris et ai, 2001). Configurational entropies were also
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calculated from the mass-weighted eigenvectors according to the method of
Schlitter as previously described in Chapter 2.
3.4 Results and discussion
3.4.1 Porting of the forcefield
Since the internal architecture of the LAMMPS code is quite different from
that of AMBER, the first test was to ensure that, given the same forcefield
and the same configuration of the macromolecule, LAMMPS and AMBER
calculated the same molecular mechanics energy for the system. Single-
point energy calculations performed using AMBER and LAMMPS on
configurations of the solvated DNA system showed excellent agreement
(Table 3.2).
ENERGY TYPE
Bond
Angle
Dihedral
Total VOW
Total Electrostatic
Total Energy
AMBER
(kcal/mol)
0.0239
399.8833
438.7989
2532.0560
-27167.3825
-23796.6204
LAMMPS
(kcal/mol)
0.0239
399.8833
438.7989
2532.2143
-27167.0726
-23796.1522
Table 3.2 - Static energy analysis, using both AMBER and LAMMPS, of a
representative structure of the DNA duplex d(CTTTTGCAAAAG)2.
Bond, angle and dihedral energies are identical, however there are very
small differences in the calculated van der Waals and electrostatic energies.
However, since these are sums over a very large number of individual
interactions, such differences were not regarded as significant. While such an
analysis confirms that LAMMPS and AMBER calculate essentially the same
energies given identical input structures, it does not show that the calculated
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Calculation of individual solvent and solute temperatures revealed that the
simulations suffered from the 'hot solute, cold solvent' problem. Switching to
Langevin coupling, with separate scaling of solvent and solute temperatures,
overcame this problem and led to simulations where the overall flexibility of
the DNA was essentially indistinguishable from its behaviour in AMBER
simulations. However, when this study began the use of Langevin coupling
was incompatible with RESPA and SHAKE was not implemented, so stable
simulations required the expense of the full evaluation of all energy terms
every 1 fs time step. This obviously affected the practical comparison of
attainable speeds with AMBER.
3.4.3 Analysis ofsimulations on the DNA alone - similarity analysis
With a suitable temperature coupling method established, extended
simulations were carried out in order to determine values for key parameters
that would bring the dynamic and thermodynamic characteristics of the
system as close as possible to those previously obtained using AMBER.
Initial studies were handicapped by the inability to combine the necessary
Langevin temperature control method with the efficient RESPA energy/force
evaluation method and SHAKE not being implemented within the code;
however, later in these studies updated releases of LAMMPS were produced
permitting use of both RESPA and SHAKE. Therefore, the parameters
concentrated on most closely were a) the temperature coupling parameter
and b) the use or otherwise of time saving algorithms (RESPA and SHAKE).
Each simulation (Table 3.3) was run on 64 processors and analysis was
carried out on 2ns equilibrated portions of the trajectories.
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SIMULATION 10
LAMMPS 1
LAMMPS 2
LAMMPS 3
RESPA 1
RESPA2
RESPA 3
SHAKE
TEMP
COUPLING (fs-1)
------ ---
-------
0.01
0.001
0.0001
0.01
0.001
0.0001
0.001
RESPAISHAKE?
NONE
NONE
NONE
RESPA
RESPA
RESPA
SHAKE
Table 3.3 - Details of the simulations carried out on the free DNA.
The similarity between the results obtained in each case and the benchmark
AMBER simulation was assessed using four measures. The first was the
root-mean-square Cartesian co-ordinate deviation between the time-
averaged structure obtained using LAMMPS and that from AMBER. This
gives a static structural measure of similarity. The second was a comparison
of the average energy of the solute in each LAMMPS simulation compared to
that obtained using AMBER. For this, each snapshot from the 2 ns
trajectories was stripped of its waters and counter-ions, and used as the input
for a single-point energy calculation in AMBER, using the GB/SA method to
provide a solvation term. This permitted a direct comparison with previous
AMBER data for this DNA sequence. Thirdly, the configurational entropy of
each LAMMPS trajectory was calculated, and compared to that obtained
using AMBER. This gives a general but very sensitive measure of how the
dynamics of the systems compare, and is particularly important if the ultimate
desire is to calculate thermodynamic quantities from such simulations.
Fourthly, the dynamics of each simulation was investigated in more detail
through the comparison of principal components (see previous chapter).
3.4.3. 1 Results from the similarity analysis
The results obtained are shown in Table 3.4. The coupling parameter for the
Berendsen thermostat used in the reference AMBER studies was expected
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to be equivalent to a 0.001 ts' coupling parameter for the Langevin
thermostating used in LAMMPS. However, initial simulations performed
without RESPA or SHAKE indicated that a weaker temperature coupling
(0.0001 fs') gave results slightly closer to those obtained using AMBER.
This weakening in the temperature coupling had no discernable effect on the
average energetics of the DNA dodecamer duplex, but, unsurprisingly, led to
increasing configurational entropy. Looser temperature coupling also led to
the major modes of deformation of the DNA resembling more closely those
obtained using AMBER (increased peA overlap).
RMSD (A) -=SYSTEM AVERAGE T*ENTROPY PCAOVERLAP
ENERGY (bond (TS) kcal/mol
energy removed)
kcal/mol
- ---_.._-"---,,-- ' ~ - - - - ' - - - - - ' - _ . _ ' - ' ' ' - ' ' _ . _ - - - - - ' . - . - - ' ' ' ' ' ' ' - - - -----_._ .._ - - - " . _ ~ - - - - -
AMBER n/a -4397.95 693.67 n/a
LAMMPS 1 0.95 -4442.87 589.79 0.4214
LAMMPS 2 0.65 -4444.15 637.56 0.6309
LAMMPS 3 0.63 -4443.27 646.17 0.6678
RESPA 1 2.24 -4437.09 695.99 0.6211
RESPA2 0.58 -4443.38 727.13 0.6315
RESPA 3 0.73 -4443.33 713.28 0.6867
SHAKE 0.59 -4435.32 732.07 0.6796
- - ' . - _ . - . - ~ - . - - ....._ " " ' " ' " . ; . . - - . ~ - - -""'>'......." " " ' ' ' ' ' ' ' ' ' ....
Table 3.4 - Benchmark comparisons for LAMMPS simulations of
d(CTTTTGCAAAAG)2 against the previous AMBER results.
When the equivalent simulations were repeated using RESPA, there were
some differences. Firstly, while the tightest temperature coupling (0.01 fs")
clearly led to a poor average structure and an average energy which differed
from the other LAMMPS simulations, the two weaker coupling constants
provided trajectories with varying merits. A coupling constant of 0.001 ts'
provided the best (lowest RMSD) time-averaged structure (Figure 3.6) but a
coupling constant of 0.0001 fs-1 provided a trajectory with principal
components closest to those obtained using AMBER.
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the same system using the same MD code lead to trajectories with PCA
overlaps of around 0.7 (Sherer E.C, unpublished data), so the LAMMPS
simulation run using SHAKE may be regarded as dynamically
indistinguishable from the AMBER simulation, while the RESPA simulation is
only slightly poorer.
The other LAMMPS simulations carried out confirm the trend for lower
average energies compared to AMBER. To identify the source of this, we
performed energy decomposition analysis on the AMBER, RESPA 2 and
SHAKE simulations (Table 3.5). This shows that LAMMPS generated
structures have more negative 1-4 electrostatic energy (1-4 EEL) and
solvation (EGB) terms though this is partly countered for by a less favourable
general electrostatic energy (EEL) term.
: M I \ . ~ , , , , = =
SYSTEM BOND ANGLE OIHEO 1-4 VOW 1-4 EEL VOW EEL EGB
AMBER 0.28 393.29 439.73 212.79 -1748.53 -407.63 -705.20 -2582.68
RESPA 2 277.11 405.49 436 .70 201.41 -1810.25 -406.83 -646.28 -2621.25
SHAKE 190.46 409.45 437 .70 202.32 -1806.33 -408.24 -647.44 -2622.77
" " " " - - - ~ ' " ' - - ~ ~
Table 3.5 - Energy decomposition of LAMMPS simulations (RESPA and
SHAKE) compared to previous AMBER results. All values are in kcal/ mol and
are averages over 1000 snapshots taken from the MD simulations)
However, a similar analysis of the drug-DNA complex simulations (discussed
below) revealed that the overall energy difference of 40-50 kcal/mol between
AMBER and LAMMPS simulations was still evident, this resulted from
different balances between the same three key terms (1-4 EEL, EGB and
EEL). The one constant feature is an approximately 60 kcal/mol more
negative value for the 1-4 electrostatic energy term in LAMMPS simulations.
Since we have already shown that, given identical conformations of the DNA,
both AMBER and LAMMPS calculate identical values for dihedral terms, the
source of this discrepancy still remains to be determined. One possibility is
that in the original AMBER simulations SHAKE was used to constrain all
bond lengths, whereas in LAMMPS, to permit efficient parallelisation, only
bonds to hydrogen atoms are constrained. However, since we find that
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LAMMPS gives very similar results using SHAKE and RESPA (where no
bonds are constrained) this seems unlikely.
3.4.4 Analysis of drug-DNA complexes - similarity and thermodynamic
analysis
Though clearly we have identified protocols for LAMMPS simulations that
bring derived thermodynamic parameters into reasonable agreement with
those calculated using AMBER, it is more important, for most purposes, that
differences in enthalpies and entropies between systems or states are the
same, irrespective of the MD code used to generate the configurations. To
test this additional simulations were performed using LAMMPS on the 1:1
and 2:1 complexes between this DNA duplex and the minor drug binder
Hoechst 33258 .
These simulations were performed analogously to the RESPA 2 and SHAKE
simulations on the free DNA. Two sets of analysis were carried out on these
simulations . Firstly, a similarity analysis was carried out on the 1:1 and 2:1
complex simulations. The drug atoms were stripped out, leaving just the
DNA molecule and the resulting trajectories were put through the same
analysis as the free DNA, as described earlier. Secondly, the complete
trajectories were put through a thermodynamic analysis. As before, the
trajectories were post processed to calculate enthalpic plus solvation terms
using the GB/SA method and configurational entropies were calculated via
the Schlitter approach . From these we were able to estimate, as before
(Harris et aI, 2001), the differences in the free energy change between the
first and second binding event ( ~ ~ G ) ) which has been shown by NMR
(Gavathiotis et et, 2000) to be at least -4.0 kcallmol.
3.4.4.1 Results from similarity analysis
The agreement with the previous AMBER results is shown in Table 3.6.
These results show that the RMSD values get smaller (showing an increase
in similarity in the time-averaged structures) and the peA overlaps get larger
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(showing increased dynamical similarity) when the drugs bind to the DNA.
This is as expected as the DNA gets more rigid as the drugs bind to its minor
groove. The RESPA and SHAKE results show excellent RMSD and peA
overlap values.
(a) 1: 1 drug-DNA complex results
SYSTEM RMSD (A) AVERAGE T*ENTROPY PCA OVERLAP
ENERGY (bond (TS) kcal/mol
energy removed)
.-...._.---- --- - -_ .- -
kcal/mol
AMBER
- - ----_.__ .._._--_._- . _._----_._--- - - _ .._- -- - -___.__0_ - - ·----_·_··
n/a -4397.56 678 .67 n/a
RESPA 0.68 -4437 .67 704 .98 0.6972
SHAKE 0.50 -4433.84 715.47 0.7194
(b) 2: 1 drug-DNA complex results
SYSTEM
AMBER
RESPA
SHAKE
RMSD(A) AVERAGE
ENERGY (bond
energy removed)
kcal/mol
n/a -4394.60
0.51 -4443.38
0.53 -4427.85
T*ENTROPY
(TS) kcaI/mol
669 .39
693.00
700.53
PCA OVERLAP
n/a
0.7854
0.7743
Table 3.6 - Benchmark comparisons of the 1:1 and 2:1 drug-DNA complexes
against the previous AMBER results.
As stated earlier there is still a 40-50 kcal/mol difference in the enthalpies
calculated from LAMMPS from those calculated from AMBER. As before,
energy decompositions were carried out (Table 3.7) and the major
differences were again in the 1-4 EEL, EGB and EEL terms. The entropies
generated through LAMMPS were again high in comparison to AMBER.
However, as mentioned earlier, we are more interested in the differences in
enthalpies and entropies between states, in this instance, between the free
DNA and 1:1 drug-DNA complex and between the 1:1 and 2:1 drug-DNA
complex.
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(a) 1:1 drug-DNA complex decomposition
SYSTEM BOND ANGLE OIHEO 1-4 VOW 1-4 EEL VOW EEL EGB
AMBER
-- .- _._- _.- _.
0.12 432 .54 461 .97 230.59 -1709.86 -475.33 -971.93 -2394.76
RESPA 298.12 442 .80 462 .94 217.21 -1770.69 -478.05 -965.70 -2381.92
SHAKE 203.61 447 .06 464.73 218.43 -1772.91 -475.97 -986.95 -2358.77
- ~ - - - _ . - .... ._ "'...............-:...........".
(b) 2: 1 drug-DNA complex decomposition
SYSTEM BOND ANGLE OIHEO 1-4 VOW 1-4 EEL VOW EEL EGB
AMBER 0.13 470 .08
_ . _ - - - . . ~ - - . - - - _ . .
488 .36 247.96 -1670.00 -541.97 -1353.49 -2092.03
RESPA 319.71 476 .86 490 .65 233.43 -1733.69 -543.70 -1316.07 -2111.02
SHAKE 218.31 486 .31 492.37 234.98 -1731.35 -549.01 -1349.81 -2077.61
Table 3.7 - Energy decomposition of LAMMPS simulations of the 1:1 and 2:1
drug-DNA complexes, compared to previous AMBER results. All values are in
kcal/ mol and are averages over 1000 snapshots taken from the MD
simulations)
3.4.4.2 Results from the thermodynamic analysis
The agreement with the previous AMBER results is shown in Table 3.8.
AMBER simulations predicted that the binding is enthalpically anti co-
operative, ~ ~ ~ equal to 4.4 kcallmol. Using LAMMPS with SHAKE, binding
is also predicted to be enthapically anti co-operative, but only by 2.6 kcal/mol.
Using LAMMPS with RESPA, the simulations lead to the prediction that
binding is essentially unco-operative with a ~ ~ ~ of -0.1 kcallmol. AMBER
simulations predicted a strongly co-operative entropic term, ~ ~ IS of 9.6
kcal/mol, and the LAMMPS results show this too, with ~ ~ IS 1 kcal/mol more
positive in the RESPA simulation and 2.5 kcal/mol less positive in the SHAKE
simulation.
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(a) AMBER6 results
SYSTEM E ~ ~ ~ ~ ~ TS<XJ ~ T T < X X ~ ~ T T < X X
-- --- ------
--_._-- ---_... - -
Free DNA ...._ ' - ~ - - - - - - _ . _ ... .._-
-4397.95 - ~ - - - - - - - - - - - - - - - -827.06
-28.70 28.43
1:1 complex -4426.65 4.39 855.49 9.56
-24 .31 37.99
2:1 complex -4450.96 893.48
_ ~ ' ~ ~ " " _ " " " " - ' " " - - " " " ~ " ' _ _ ' " ' .' .,_ ". ''';- . . O . " " ~ . - " ' " < < . · > · r , · , , , ~ ~ - - , ,
(b) LAMMPS/RESPA results
_.... . . , , ~ " ~ " - " ~ " - " " ' - " " ~ ' .
SYSTEM E ~ ~ ~ ~ ~ TS<XJ ~ T T < X X ~ ~ T S < X X
Free DNA -4443.38 873.39
-30.02 23.94
1:1 complex -4473.40
-0.12 897.33 10.58
-30.14 34.52
2:1 complex -4503.54 931.85
(c) LAMMPS/SHAKE results
SYSTEM
= ' ,".' " -=':-'-<;''''"''l.
E ~ ~ ~ ~ ~ TS<XJ ~ T S < X X ~ ~ T S < X X
-- _ .-- -
Free DNA -4435.32 875.80
-28.99 32.64
1:1 complex -4464.31 2.57 908.44 7.02
-26.42 39.66
2:1 complex -4490.73 948.10
... __ ~ o ; , . " " " " , , ~ , , ~ ' - ~ ~__ . ... ~ ~ . --- ' " " " " = . : - . = = = . " . , . . ~ " " = .....,...=.,=-
Table 3.8 - Thermodynamical analysis of LAMMPS simulations compared to
previous AMBER6 results (T = 300 K). All values are averages over 1000
snapshots from each simulation and are in kcal/ mol.
Taken together, the AMBER simulations predict an overall ~ ~ ~ of -5.2
kcal/mol, while our LAMMPS simulations predict ~ ~ ~ to be -10.7 kcal/mol
(using RESPA) and -4.5 kcallmol (using SHAKE), /1/1G terms are calculated
from /1/1E - /1/1TS; values, where the E terms equate with system enthalpy.
Overall we see that, as expected, while absolute energies and entropies from
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the different simulations can differ somewhat, differences and double
differences are well reproduced. While it is clear that quantitatively the
results are slightly different from the benchmark (more so for the RESPA
simulations than the SHAKE ones), the important qualitative conclusions
from the study are the same: that the observed highly co-operative binding of
Hoechst 33258 to this DNA dodecamer is entropy, not enthalpy driven.
3.4.5 Analysis of Computational Efficiency
The above analysis confirms that LAMMPS is reliable for such simulations -
but is it useful? For this it must show a significantly improved performance
on massively parallel computers, so that simulation problems that are difficult
or impossible to handle using conventional codes can now be tackled
routinely. To examine this a series of 1Ops simulations were performed using
different numbers of processors using both AMBER and the various versions
of LAMMPS. In an ideal case, doubling the number of processors used for a
calculation would halve the time required for solution. However, as discussed
in the introduction, this is seldom the case in practice.
The efficiency of each simulation was calculated according to the equation:
Efficiency =np*UI,
where np is the number of processors, t the wallclock time taken for
completion of the computation (in seconds), and I is the length of the
simulation (in femtoseconds).
The results are shown in Figure 3.7, with efficiencies normalised so that they
are relative to the performance of LAMMPS using SHAKE when run on a
single node of the Cray T3E.
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processors used - i.e. when using two processors instead of one the time
,
taken to complete the simulation more than halves. Above 8 processors
LAMMPS performance begins to fall off somewhat, but always remains
superior to that of AMBER.
In practice, 1ns of the AMBER simulation of the 12mer sequence described
earlier took around 10 days to complete on one processor of a SGI Origin
200; the corresponding 1ns LAMMPS simulation, using SHAKE, took around
6.6 hours to complete on 64 processors of a Cray T3E.
3.5 Summary
The Amber98 forcefield , 'native' to the MD code AMBER which is widely
used and respected for molecular dynamics studies of both DNA and
proteins, has been successfully implemented in LAMMPS. The
implementation has been validated, at least as far as the simulation of
nucleic acid systems is concerned, by a careful analysis of MD data
generated from a DNA system that has been the subject of detailed previous
study using AMBER itself.
To perform the validation we have had to consider carefully what constitutes
similarity between two MD simulations and have settled on the following
benchmarks that we consider testing, though not comprehensive. Firstly, and
most trivially, calculations of static energies for snapshots of the system must
be in agreement between the two MD codes. Secondly, over well-equilibrated
portions of trajectories, averages of energies and energy components must
be in agreement. Thirdly, the dynamical behaviour of the systems must be in
agreement, and the measurement of PCA overlaps provides a useful method
of checking this. Fourthly, non-enthalpic terms calculable from the MD
ensembles must be in agreement, and the determination of configurational
entropies provides this test.
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With optimised simulation parameters, LAMMPS passes all these tests when
compared to AMBER, and offers much improved performance in massively
parallel environments. While AMBER and LAMMPS simulations can produce
slightly different absolute values for enthalpic and entropic quantities, it is
usually the case that enthalpy and entropy differences are the observables,
and these are well reproduced. The validation of LAMMPS opens up
significant new horizons for high performance biomolecular computing.
Order-of-magnitude increases in the sizes of problems that may be
addressed - in terms of numbers of atoms per simulation, where scalability
will be even more dramatic - are also now within reach. Order of magnitude
increases in simulation timescales will make new problems amenable to
analysis through atomistic molecular dynamics simulations. Conversely, for
problems where current sizes and MD timescales suffice, time-to-solution
may be reduced ten-fold or more.
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CHAPTER 4 - MOLECULAR DYNAMICS APPROACHES TO
CALCULATING BINDING AFFINITIES - APPLIED TO A
NOVEL CLASS OF TELOMERASE INHIBITORS.
4.1 Telomeres and Telomerase
4.1.1 The role of telomeres
Telomeres are guanine rich sequences of DNA found at the end of
chromosomes. In humans, the terminal approximately 10 kilobases (kb) of
chromosomes are made up of tandem repeats of the telomeric sequence
ITAGGG (Blackburn, 1991). These telomeres protect the chromosomes
ends from end-to-end fusion, exonuclease degradation and aberrant
recombination (Perry & Jenkins, 1999 and references therein), and by doing
so maintain the integrity of the genetic information stored in the DNA.
Telomeric DNA is generally double stranded except for the extreme 3' end of
the telomere, which consists of a single stranded overhang. This single
strand is formed during DNA replication because DNA polymerase cannot
fully replicate the extreme 3' end during lagging strand synthesis. This is
known as the "end replication problem" (Watson, 1972) and results in the
loss of around 50-100 base pairs per cell division. This could lead to
dangerously short telomeres and the possibility that genes would not be fully
replicated causing major problems upon transcription. Cells do not allow this
to happen, they are not able to divide indefinitely and have a pre-determined
proliferative lifespan to stop this occurring, termed the Hayflick limit (Hayflick,
1961). Human somatic cells can undergo around 50-80 cell divisions before
reaching their Hayflick limit, at which time they undergo cell cycle arrest
(senescence) and stop dividing.
Although senescence is an irreversible process, there are cells that are able
to escape the process. Once the Hayflick limit is reached within a cell, the
telomere shortening signal is transduced to tumour suppressor pathways
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controlled by p53 and retinoblastoma (Rb) which lead to senescence or
apoptosis (Leong & Seow, 2001). If p53 and Rb are inactivated by viral
oncogenes, the Hayflick limit can be overcome, cells continue to divide and
their telomeres shorten until they reach a second barrier, crisis. At this point
there is genomic instability and most cells die, although in rare cases cells
can escape crisis and become immortal. The unrestricted proliferation
shown by cells with have passed crisis is associated with the expression of
the telomerase enzyme which is able to stabilise the length of their telomeres
(Wright & Shay, 1992), implicating this enzyme in the development of
tumours .
Telomerase is also active in around 85-90% of human tumours (Kim et ai,
1994) and is responsible for the immortality of these cells. It is not normally
detected in normal somatic cells (exceptions include the immune system,
skin, intestinal lining and hair follicles; Blackburn, 2000) but is found in stem
cells which also maintain the length of their telomeres through activation of
the telomerase enzyme.
4.1.2 The telomerase enzyme
Telomerase is a ribonucleoprotein reverse transcriptase enzyme which is
capable of synthesising telomeric repeats, thus maintaining the length of
telomeres through an indefinite number of cell divisions. It is made up of two
core subunits and a number of other associated protein subunits (Figure 4.1 ).
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4.1.4 Potential problems of telomerase as an anti-cancer target
Although the development of telomerase inhibitors has been hailed as the
"next big thing" in cancer research, there are a number of potential flaws with
these types of drug. Issues of concern include: (i) the expected lag time
between telomerase inhibition and the time when telomeres reach their
critical shortness and enter senescence; (ii) the detection of telomerase
activity in the germ line, stem cells and some other cells (discussed earlier);
and (iii) the existence of alternative mechanisms of telomere maintenance
(ALT pathway) raising concerns over possible drug resistance.
Experiments carried out to determine the length of telomeres found evidence
to show that telomere lengths vary greatly across cell lines and that the
telomeres in cancer cells are generally shorter than those of normal somatic
cells (Brummendorf et ai, 2000). This is encouraging news as treatment with
telomerase inhibitors to specific cancers whose telomeres are short would
result in rapid senescence and/or apoptosis in tumour cells well before any
toxicities could occur to the germ line and stem cells which have longer
telomeres . Also, to date there is no evidence of drug-resistance emerging
(e.g. by the ALT pathway) in cancer cells exposed to telomerase inhibiting
drugs (Kelland, 2000).
4.2 Telomerase inhibition
A telomerase inhibitor should possess the ability to reduce telomerase
activity in cell extracts, preferably at the sub-micromolar level. The peR
based telomerase repeat amplification protocol (TRAP; Kim et ai, 1994)
assay has been developed to measure telomerase activity.
The classic model for telomere erosion stipulates that after -20 cell divisions,
cells will have critically short telomeres and will enter the senescent state.
This has been confirmed by experiments on HeLa cells, where these cells
lost telomeric DNA and began to die after 23-26 divisions (Feng et ai, 1995).
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The model predicts that long-term exposure of tumour cells to telomerase
inhibitors, at levels which don't cause acute cytotoxicity, should induce
telomere shortening and growth arrest (the rate depending upon initial
telomere length). Chemically related molecules that do not have any effect
on inhibition should not cause telomere shortening or senescence (Neidle &
Kelland, 1999).
There are a number of ways to inhibit telomerase, including antisense
approaches, reverse transcriptase inhibitors and quadruplex stabilising
drugs. Antisense approaches and reverse transcriptase inhibitors will be
discussed here and quadruplex stabilising drugs will be discussed later in
section 4.3.2.
4.2.1 Antisense approaches
Antisense approaches typically target the RNA component hTR, especially
the 11 base pair sequence that encodes the telomeric repeat. These types
of drugs consist of short pieces of DNA which are complementary to the
target RNA. Their mode of action is to bind to the RNA via Watson Crick
base pairing and inhibit the translation of the RNA sequence, hence no new
telomeric repeats are formed. The template RNA part of telomerase must be
exposed for new telomeric repeats to be added, therefore the target is readily
accessible.
As with any antisense strategy, there is the problem of delivery to the cell,
without a transfecting agent these types of drug do not readily enter cells.
Also if they do manage to get into the cells they are prone to degradation by
exo and endo-nuceases as they look like segments of broken DNA.
A variety of studies have been carried out on antisense oligonucleotides
which target the template and non-template regions of hTR. Many have
reported a reduction in telomerase activity, but most have not reported
reduced telomere length with continued treatment (White et aI, 2001 and
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references within). The use of protein nucleic acids (PNAs) hybridised with
DNA has probably produced some of the best results to date. Improved
methods of delivery involving cationic lipids (Hamilton et ai, 1999) lead to the
exposure of PNA in cells. This lead to telomerase inhibition (with ICso values
in the nM range), telomere shortening and onset of apoptosis, dependent on
initial telomere length (Herbert et ai, 1999).
4.2.2 Reverse transcriptase inhibitors
Reverse transcriptase inhibitors are able to incorporate into viral DNA and
block chain elongation using the reverse transcriptase enzyme. Telomerase
has become a target for these types of drug because of its reverse
transcriptase (hTERT) activity . Inhibition or prevention of enzyme activity by
chain terminating nucleoside triphosphates such as 3'azido-3'deoxythymidine
(AZT, already in use for the treatment of AIDS) has been proposed. Studies
have shown these types of drugs commonly slow the growth of cells in
culture but they do not generally lead to telomere shortening or senescence.
Dideoxyguanosine inhibitors have shown some shortening of telomeres and
potent telomerase inhibition, with an ICso value of 8.6 ~ ~ against A2780 cell
extracts (Perry & Jenkins, 1999).
Problems with this type of inhibitor tend to centre on their lack of selectivity.
Other polymerases can be inhibited, including Taq polymerase which is used
in the amplification step of the TRAP assay. Therefore, inhibition of Taq
polymerase could lead to false-positive results from the TRAP assay when
analysing these drugs (Kelland, 2000).
4.3 Quadruplex DNA
The guanine rich telomeric overhang found at the ends of chromosomal DNA
is thought to adopt a higher-ordered quadruplex structure. Stabilisation of
this quadruplex structure affects the function of telomerase, as it needs a
linear strand of DNA to be able to access the hTR RNA template enabling the
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4.3.2 Inhibition of te/omerase by quadruplex stabilising drugs
The requirement of a positive ion to stabilise quadruplexes has led to
research into ligands that can mimic this positive ion and therefore enforce
stability of the quadruplex. The development of quadruplex stabilising drugs
has largely stemmed from experience with intercalating drugs for duplex and
triplex DNA. Most drugs to date are based on a planar multi-ringed
chromophore where binding is expected to occur due to TT orbital overlap with
the G-quartets. As with duplex intercalators, side chains can be added to
help with binding. This approach was supported by the fact that ethidium
bromide, an intercalating dye which binds to duplex DNA, was also found to
bind to quadruplex DNA with slightly better binding affinities ( ~ ~ = -6.8
kcallmol for duplex and i::J.G = -7.3 kcal/mol for quadruplex DNA; Guo et aI,
1992).
Evidence to support the mechanism of quadruplex stabilising drugs as
potential telomerase inhibitors came from the observation that inhibition only
occurred after 3/4 telomere repeats had been synthesised. This was
consistent with the requirement of four repeats of human telomere
d(TIAGGG) for an intramolecular quadruplex structure to form (Sun et aI,
1997).
Examples of drugs which can stabilise quadruplex DNA are porphyrins,
perylene type compounds, telomestatin, anthraquinones and acridines.
Below are a few examples with details of their merits and limitations.
4.3.2.1 Example: Porphyrins
The porphyrin TMPyP4 and its structural isomer TMPyP2 (Figure 4.9) have
been evaluated for their telomerase inhibition properties. TMPyP4 is a potent
telomerase inhibitor with an ICso value of 6 IJM whereas TMPyT2 does not
inhibit telomerase (ICso - 250 IJM; Izbicka et aI, 1999 (a)). The differences in
these properties are thought to be due to the differences in interaction with
G-quartets. TMPyP2 is sterically hindered from stacking interactions within
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Step 1 involves the formation of a binding site within the DNA (LiG
conf ) .
During this step the DNA must unwind and base pairs separate to form the
cavity into which the drug will bind. Also at this step, there will be a release
of water and counter-ions, due to the change in charge density as the
phosphate groups of DNA are separated (LiGpe) . This conformational change
is associated with a positive free energy change. Step 2 involves the transfer
of the drug from solution into the binding site (LiGhyd) . This is a hydrophobic
process as the non-polar aromatic ring system of the drug is removed from
solution and placed into the cavity formed in step 1. This hydrophobic
transfer is associated with a negative free energy change and will also result
in release of more counter-ions if the drug is positively charged. The final
step involves molecular interactions such as hydrogen bonding, vdW,
electrostatic, and stacking interactions to tether the drug into position (LiGmol) .
This step is also associated with a negative free energy change. Each of
these steps contributes to the overall binding free energy.
The method of parsing free energy into contributions (Chaires, 1998 and
references within) involves these four types of contributions, but also another
type - a contribution from the loss of translational and rotational motion upon
drug binding (LiG t+r) . This then gives an overall equation describing the
contributions making up the observed free energy change upon binding
LiGobs .
LlGobs = LlGconf + LlGt+r+ LlGhyd + LlGpe + LlGmol
A detailed analysis using this parsing of the free energy was carried out on
Hoechst 33258 binding to the minor groove the d(CGCAAATTTGCGh duplex
to form a 1:1 complex (Haq et aI, 1997). The majority of the favourable
binding energy, in this case, arises from the hydrophobic transfer of ligand
from solvent to binding site in the minor groove.
Not all of these contributions are easily calculated via experimental and
theoretical techniques therefore, free energy of binding is generally
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calculated using binding constants (Kb) or enthapic (LiH) and entropic (TLiS)
values via the following equations .
LlGblnd = -RT InKb LlGbind =LlH- TLlS
4.4.1 Calculations of LlGbind by experimental methods
To measure binding free energies by means of binding constants (Kb) there
are many experimental techniques used, for example, Spectroscopic
titrations , surface plasmon resonance (SPR) and Isothermal titration
calorimetry (ITC).
Spectroscopic titrations involve the titration of a drug into a known
concentration of DNA (or vise versa) to construct equilibrium binding
isotherms. The data can then be analysed using thermodynamic models to
obtain the binding constant (Chaires, 2001).
SPR involves immobilizing one of the reacting species (typically the DNA)
onto a gold sensor chip. The other component (the drug) is then passed over
the chip and binding interactions are detected by measuring the refractive
index of the chip. The data is analysed by construction of a binding curve
(Davis & Wilson , 2001).
In Isothermal titration calorimetry (ITC) a binding curve is obtained, defined
by the amount of heat released or absorbed as a function of the total
concentration of ligand, and analysed using an appropriate model (Haq, 2002
and references therein). ITC can also be used to calculate changes in
enthalpy and hence entropic contributions can also be inferred via the
equation above.
4.4.2 Calculation ofLlGbind by computational techniques
The calculation of LiGbind by computational techniques has been hampered
by the lack of a universally accepted method for calculating entropic terms.
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Many methods have been developed to get round this problem including LIE
(discussed in chapter 2) and MMPBSA (part of the AMBER6 suite of
programs; Case et aI, 1999), which do not involve the calculation of
configurational entropy terms but implicitly take into account solvent
associated terms.
There have been few groups who have tried to calculate ~ G b i n n for
quadruplex stabilising drug via computational techniques. Cairns et aI,
(2002) studied the binding of anthraquinones to quadruplex DNA via
computational binding enthalpies ~ E b i n d d Their binding enthalpies were
calculated using the equation ~ E b i n n = Ecomplex - (Edrug + EDNA), a similar
method to how we have calculated ~ G b i n n (see section 4.7.1 later) but without
the need for entropic data. Although the method neglects any entropic
contributions, they have found good correlations between experimental and
computational data.
Read et aI, (1999; 2001) have used a method adapted from the LIE approach
to calculate binding affinities for their acridine based drugs. They have found
that although the actual energies are not identical to results from
experiments, the rankings from this method are in accord with biochemical
measurements of telomerase inhibition and binding enthalpies determined
via ITC.
In the rest of this chapter we will evaluate a number of different
computational methods for predicting binding affinities and interactions using
quadruplex DNA and two new polycyclic quino-acridines synthesised within
our labs in Nottingham.
4.5 Polycyclic quino-acridines - a novel class of telomerase
inhibitors
At Nottingham, a series of biologically active polycyclic quino-acridines have
been developed (Heald, 2002 (b)) based on acridine compounds. The lead
compound of the series is RHPS4, a difluorinated derivative (Figure 4.16)
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which shows high and selective affinity, in vitro, for quadruplex DNA and
good telomerase inhibitory activity via the TRAP assay (Kim et aI, 1994). A
related molecule RHPS3 (Figure 4.16), shows much less selectivity for
quadruplex over duplex DNA, but a similar TRAP assay result. Figure 4.16
shows the structures of RHPS4 and RHPS3 along with experimental results
including TRAP assay, Glso, Competition dialysis and SPR binding.
As already stated both drugs have similar TRAP assay results with RHPS3
being a slightly better telomerase inhibitor. The Giso results are higher for
RHPS4 than RHPS3 indicating that RHPS4 is more selective to quadruplex
DNA and therefore less cytotoxic than RHPS3. The competition dialysis
results (Modi, 2002) show that RHPS4 has a greater affinity for higher
ordered structures than RHPS3 and the SPR binding constants (Kb; Wilson,
unpublished results) show that the selectivity of RHPS4 for quadruplex over
duplex DNA is due to RHPS4 haVing stronger binding to quadruplex and
poorer binding to duplex DNA in comparison to RHPS3.
Lack of selectivity for quadruplex DNA is undesirable as it is correlated with
general unselective cytotoxicity, an unacceptable phenomena for a selective
drug. It is because although structurally very similar, there are major
differences in binding and selectivity for RHPS4 and RHPS3 (described
above), that these two molecules were chosen to be studied by molecular
modelling. The aim of this modeling being to try to understand the origins of
their differing affinities, so as to guide the future development of the series of
drugs.
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